Tag: Kathrin U. Jansen

Pfizer to invest $95m in French specialty vaccine company Valneva

businessnewstoday- June 22, 2022 0

US pharma giant Pfizer said that it will invest $95 million in Valneva, a French specialty vaccine company, for an 8.1% stake. The two firms ... Read More

Pfizer RSVpreF vaccine candidate gets another FDA breakthrough therapy status

businessnewstoday- March 27, 2022 0

Pfizer said that PF-06928316 (RSVpreF), its respiratory syncytial virus (RSV) vaccine candidate, has been granted breakthrough therapy designation from the US Food and Drug Administration ... Read More

Pfizer gets FDA breakthrough status for RSVpreF RSV vaccine candidate

businessnewstoday- March 5, 2022 0

Pfizer has secured breakthrough therapy designation for its respiratory syncytial virus (RSV) vaccine candidate — PF-06928316 (RSVpreF) from the US Food and Drug Administration (FDA) ... Read More

Pfizer begins phase 3 clinical trials of 20vPnC, RSVpreF, and MenABCWY vaccine candidates

pharmanewsdaily- June 22, 2020 0

US pharma giant Pfizer has initiated four phase 3 clinical trials within its present pipeline of investigational vaccines. The company's 20vPnC, which is a 20-valent ... Read More